Maryland generic drug maker, Jubilant Cadista Pharmaceuticals, is recalling one lot of drospirenone and ethinyl estradiol birth control pills over concerns that they may not work as prescribed.
The pills were distributed to wholesalers, suppliers and retailers, for failing to meet specifications or “acceptance criteria for dissolution,” Jubilant says.
The FDA recall notice states, “Product efficacy may be decreased due to incomplete absorption of the active ingredients.
What you need to know: Drospirenone and Ethinyl Estradiol Tablets, USP, has been identified as Lot number 183222, with NDC number 59746-763-43 and expiration date of 11/2020.
Concerned consumers can contact Jubilant Cadista Pharmaceuticals Inc. directly by calling Inmar at 1-855-205-9246 and arrange to return the affected product.
The company recommends calling your physician or healthcare provider if you have experienced any adverse reactions related to use of this product.
Adverse reactions can also be reported to FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Have you been affected by this recall? Do you have information about another recall we should cover? You can also shoot us an email to Outreach@ConsiderTheConsumer.com. You can also find us on Twitter, Facebook, Instagram, LinkedIn, or even connect with us directly on our website!
About the Author: Aisha K. Staggers is a writer, lecturer, political analyst and literary agent. She appears weekly for “Staggers’ State of Things” on the Dr. Vibe Show. Her work has been published by Paper Magazine, AfroPunk, The Spool, GREY Journal, MTV News, HuffPost, Blavity, Atlanta Blackstar, For Harriet, New York Review of Books and a host of other first-run publications and syndicated outlets. Find her on Twitter @AishaStaggers. For more of her work, check out her page here!